HUBEI GOTO BIOPHARM CO., LTD.

Hubei Goto Biopharm Co., Ltd. was established in 2006 and headquartered in Xiangyang City, Hubei Province, is a high-tech enterprise specializing in the R&D, production and sales of starting materials, intermediates and APIs for steroid drugs. The company was listed on the GEM of Shenzhen Stock Exchange on April 9, 2021. (Stock code is 300966.SZ) The company's main products are starting materials, intermediates and APIs essential for the production of steroid drugs. It is a trailblazing enterprise in the field of starting materials for steroid drugs. It has its comprehensive product supply chain on corticosteroids, sex hormones, and progestogens because of its huge advantage on steroid starting material. Goto Biopharm has been a consequential R&D, production and supply base for domestic steroid drug intermediates. The company not only has three major production bases like Goto Biopharm, Goto Biotech and Sightlead Pharm, but also has R&D center in Wuhan. The production workshop at the base has solid production equipment, reasonable production processes, comprehensive quality management and strict testing systems to ensure that product quality meets regulations and customer requirements, and product production meets GMP requirements and certification. The company's R&D center mainly focuses on R&D and innovation in molecular biology, enzyme engineering, fermentation engineering, and chemical synthesis. An efficient and stable R&D platform and team of experts not only accelerate the innovation of the company's new products and new technical processes, but also become the company's core competitiveness for winning in the global market.